Skip to main content Skip to main navigation menu Skip to site footer
  • \
    Start Submission Become a Reviewer

    Direct mechanical thrombectomy with or without thrombolysis for acute ischemic stroke

    • Xuebing Feng
    • Yunying Feng
    • Jie Wang
    • Xin Xu
    • Yueqiao Xu


    Abstract

    The efficacy of direct mechanical thrombectomy (MT) and thrombectomy combined with intravenous thrombolysis (MT+IVT) in patients with acute ischemic stroke is still unclear. To comprehensively analyze the two strategies, we conducted a meta-analysis of randomized controlled trials (RCTs). Six RCTs were recruited from Ovid Medline, Embase, and Cochrane Central Register of Controlled Trials and published from 2020 to 2023, including 1164 in the MT group and 1170 in the MT + IVT group. There was no significant difference between the MT group and MT+IVT group in 90-day favorable outcome (OR 0.93, 95% CI 0.79-1.09, P=0.37, I2=0%,) and excellent outcome (OR 0.98, 95% CI 0.82-1.18, P=0.82, I2=0%). Similarly, there was no significant difference in 90-day mortality (OR 1.08, 95% CI 0.86-1.35, P=0.52, I2=0%) and symptomatic intracranial hemorrhage (OR 0.82, 95% CI 0.57-1.19, P=0.30, I2=0%). However, the successful recanalization rate of the MT group was significantly lower than that of the MT+IVT group (OR 0.73, 95% CI 0.57-0.94, P=0.01, I2=0%). There was no significant difference in functional outcome and safety endpoints between direct MT and MT+IVT, but the successful recanalization rate of MT+IVT was higher.

    Keywords: Mechanical Thrombectomy Thrombolysis Ischemic Stroke Meta-Analysis RCTs
    Section

    References

    1. Collaborators GBDS. Global, regional, and national burden of stroke and its risk factors, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Neurol. 2021;20(10):795-820.
    2. Casetta I, Pracucci G, Saletti A, Saia V, Padroni M, De Vito A, et al. Combined intravenous and endovascular treatment versus primary mechanical thrombectomy. The Italian Registry of Endovascular Treatment in Acute Stroke. Int J Stroke. 2019;14(9):898-907.
    3. Bhatia R, Hill MD, Shobha N, Menon B, Bal S, Kochar P, et al. Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action. Stroke. 2010;41(10):2254-8.
    4. Katsanos AH, Malhotra K, Goyal N, Arthur A, Schellinger PD, Kohrmann M, et al. Intravenous thrombolysis prior to mechanical thrombectomy in large vessel occlusions. Ann Neurol. 2019;86(3):395-406.
    5. Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, et al. Guidelines for the Early Management of Patients With Acute Ischemic Stroke: 2019 Update to the 2018 Guidelines for the Early Management of Acute Ischemic Stroke: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2019;50(12):e344-e418.
    6. Rodrigues FB, Neves JB, Caldeira D, Ferro JM, Ferreira JJ, Costa J. Endovascular treatment versus medical care alone for ischaemic stroke: systematic review and meta-analysis. BMJ. 2016;353:i1754.
    7. Fischer U, Kaesmacher J, Mendes Pereira V, Chapot R, Siddiqui AH, Froehler MT, et al. Direct Mechanical Thrombectomy Versus Combined Intravenous and Mechanical Thrombectomy in Large-Artery Anterior Circulation Stroke: A Topical Review. Stroke. 2017;48(10):2912-8.
    8. Mistry EA, Mistry AM, Nakawah MO, Chitale RV, James RF, Volpi JJ, et al. Mechanical Thrombectomy Outcomes With and Without Intravenous Thrombolysis in Stroke Patients: A Meta-Analysis. Stroke. 2017;48(9):2450-6.
    9. Kaesmacher J, Mordasini P, Arnold M, López-Cancio E, Cerdá N, Boeckh-Behrens T, et al. Direct mechanical thrombectomy in tPA-ineligible and -eligible patients versus the bridging approach: a meta-analysis. J Neurointerv Surg. 2019;11(1):20-7.
    10. Podlasek A, Dhillon PS, Butt W, Grunwald IQ, England TJ. Direct mechanical thrombectomy without intravenous thrombolysis versus bridging therapy for acute ischemic stroke: A meta-analysis of randomized controlled trials. International Journal of Stroke. 2021;16(6):621-31.
    11. Wang Y, Wu X, Zhu C, Mossa-Basha M, Malhotra A. Bridging Thrombolysis Achieved Better Outcomes Than Direct Thrombectomy After Large Vessel Occlusion: An Updated Meta-Analysis. Stroke. 2021;52(1):356-65.
    12. LeCouffe NE, Kappelhof M, Treurniet KM, Rinkel LA, Bruggeman AE, Berkhemer OA, et al. A Randomized Trial of Intravenous Alteplase before Endovascular Treatment for Stroke. New England Journal of Medicine. 2021;385(20):1833-44.
    13. Suzuki K, Matsumaru Y, Takeuchi M, Morimoto M, Kanazawa R, Takayama Y, et al. Effect of Mechanical Thrombectomy Without vs With Intravenous Thrombolysis on Functional Outcome Among Patients With Acute Ischemic Stroke: The SKIP Randomized Clinical Trial. Jama. 2021;325(3):244-53.
    14. Yang P, Zhang Y, Zhang L, Zhang Y, Treurniet KM, Chen W, et al. Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke. N Engl J Med. 2020;382(21):1981-93.
    15. Zi W, Qiu Z, Li F, Sang H, Wu D, Luo W, et al. Effect of Endovascular Treatment Alone vs Intravenous Alteplase Plus Endovascular Treatment on Functional Independence in Patients With Acute Ischemic Stroke: The DEVT Randomized Clinical Trial. JAMA. 2021;325(3):234-43.
    16. Mitchell PJ, Yan B, Churilov L, Dowling RJ, Bush SJ, Bivard A, et al. Endovascular thrombectomy versus standard bridging thrombolytic with endovascular thrombectomy within 4·5 h of stroke onset: an open-label, blinded-endpoint, randomised non-inferiority trial. Lancet. 2022;400(10346):116-25.
    17. Fischer U, Kaesmacher J, Strbian D, Eker O, Cognard C, Plattner PS, et al. Thrombectomy alone versus intravenous alteplase plus thrombectomy in patients with stroke: an open-label, blinded-outcome, randomised non-inferiority trial. Lancet. 2022;400(10346):104-15.
    18. Page MJ, Moher D, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. PRISMA 2020 explanation and elaboration: updated guidance and exemplars for reporting systematic reviews. BMJ. 2021;372:n160.
    19. von Kummer R, Broderick JP, Campbell BC, Demchuk A, Goyal M, Hill MD, et al. The Heidelberg Bleeding Classification: Classification of Bleeding Events After Ischemic Stroke and Reperfusion Therapy. Stroke. 2015;46(10):2981-6.
    20. Tissue plasminogen activator for acute ischemic stroke. The New England journal of medicine. 1995;333(24):1581-7.
    21. Higgins JP, Altman DG, Gotzsche PC, Juni P, Moher D, Oxman AD, et al. The Cochrane Collaboration's tool for assessing risk of bias in randomised trials. BMJ. 2011;343:d5928.
    22. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327(7414):557-60.
    23. Phan K, Dmytriw AA, Lloyd D, Maingard JM, Kok HK, Chandra RV, et al. Direct endovascular thrombectomy and bridging strategies for acute ischemic stroke: a network meta-analysis. J Neurointerv Surg. 2019;11(5):443-9.
    24. Yarbrough CK, Ong CJ, Beyer AB, Lipsey K, Derdeyn CP. Endovascular Thrombectomy for Anterior Circulation Stroke: Systematic Review and Meta-Analysis. Stroke. 2015;46(11):3177-83.
    25. Vidale S, Romoli M, Clemente Agostoni E. Mechanical thrombectomy with or without thrombolysis: A meta-analysis of RCTs. Acta Neurol Scand. 2021;143(5):554-7.
    26. Powers WJ, Derdeyn CP, Biller J, Coffey CS, Hoh BL, Jauch EC, et al. 2015 American Heart Association/American Stroke Association Focused Update of the 2013 Guidelines for the Early Management of Patients With Acute Ischemic Stroke Regarding Endovascular Treatment: A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke. 2015;46(10):3020-35.
    27. Imbarrato G, Bentley J, Gordhan A. Clinical Outcomes of Endovascular Thrombectomy in Tissue Plasminogen Activator versus Non-Tissue Plasminogen Activator Patients at Primary Stroke Care Centers. J Neurosci Rural Pract. 2018;9(2):240-4.
    28. Pérez de la Ossa N, Abilleira S, Jovin TG, García-Tornel Á, Jimenez X, Urra X, et al. Effect of Direct Transportation to Thrombectomy-Capable Center vs Local Stroke Center on Neurological Outcomes in Patients With Suspected Large-Vessel Occlusion Stroke in Nonurban Areas: The RACECAT Randomized Clinical Trial. Jama. 2022;327(18):1782-94.
    29. Duncan PW, Jorgensen HS, Wade DT. Outcome measures in acute stroke trials: a systematic review and some recommendations to improve practice. Stroke. 2000;31(6):1429-38.

    How to Cite

    “Direct Mechanical Thrombectomy With or Without Thrombolysis for Acute Ischemic Stroke”. Human Brain, vol. 3, no. 1, July 2024, https://doi.org/10.37819/hb.1.1811.
    ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver
    Download Citation
    Endnote/Zotero/Mendeley (RIS) BibTeX

    How to Cite

    “Direct Mechanical Thrombectomy With or Without Thrombolysis for Acute Ischemic Stroke”. Human Brain, vol. 3, no. 1, July 2024, https://doi.org/10.37819/hb.1.1811.

    HTML
    55

    Total
    42

    Share

    Search Panel

    Xuebing Feng
    Google Scholar
    Pubmed
    JDMFS Journal

    Yunying Feng
    Google Scholar
    Pubmed
    JDMFS Journal

    Jie Wang
    Google Scholar
    Pubmed
    JDMFS Journal

    Xin Xu
    Google Scholar
    Pubmed
    JDMFS Journal

    Yueqiao Xu
    Google Scholar
    Pubmed
    JDMFS Journal

    Downloads

    Article Details

    Most Read This Month

    License

    Copyright (c) 2024 Xuebing Feng, Yunying Feng, Jie Wang, Xin Xu, Yueqiao Xu

    Creative Commons License

    This work is licensed under a Creative Commons Attribution-NoDerivatives 4.0 International License.

    Copyright © 2023 EurAsia Academic Publishing Group. All rights reserved